Functional analysis of two SLC9A6 frameshift variants in lymphoblastoid cells from patients with Christianson syndrome
CNS Neuroscience & Therapeutics · 2023
DOI: 10.1111/cns.14329 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2023. Verfasst von Hailan He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Epilepsy, Microcephaly. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R & D Program of Hunan Province, National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Background
Christianson syndrome (CS) is caused by mutations in SLC9A6 and is characterized by global developmental delay, epilepsy, hyperkinesis, ataxia, microcephaly, and behavioral disorder. However, the molecular mechanism by which these SLC9A6 mutations cause CS in humans is not entirely understood, and there is no objective method to determine the pathogenicity of single SLC9A6 variants.
Methods
Trio‐based whole exome sequencing (WES) was carried out on two individuals with suspicion of CS. qRT‐PCR, western blot analysis, filipin staining, lysosomal enzymatic assays, and electron microscopy examination, using EBV‐LCLs established from the two patients, were performed.
Results
Trio‐based WES identified a hemizygous SLC9A6 c.1560dupT, p.T521Yfs*23 variant in proband 1 and a hemizygous SLC9A6 c.608delA, p.H203Lfs*10 variant in proband 2. Both children exhibited typical phenotypes associated with CS. Expression analysis in EBV‐LCLs derived from the two patients showed a significant decrease in mRNA levels and no detectable normal NHE6 protein. EBV‐LCLs showed a statistically significant increase in unesterified cholesterol in patient 1, but only non‐significant increase in patient 2 when stained with filipin. Activities of lysosomal enzymes (β‐hexosaminidase A, β‐hexosaminidase A + B, β‐galactosidase, galactocerebrosidase, arylsulfatase A) of EBV‐LCLs did not significantly differ between the two patients and six controls. Importantly, by electron microscopy we detected an accumulation of lamellated membrane structures, deformed mitochondria, and lipid droplets in the patients' EBV‐LCLs.
Conclusions
The SLC9A6 p.T521Yfs*23 and p.H203Lfs*10 variants in our patients result in loss of NHE6. Alterations of mitochondria and lipid metabolism may play a role in the pathogenesis of CS. Moreover, the combination of filipin staining with electron microscopy examination of patient lymphoblastoid cells can serve as a useful complementary diagnostic method for CS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China.
- Hunan Intellectual and Developmental Disabilities Research Center, Changsha, China.
- Department of Pediatric Endocrinology and Genetic Metabolism, Xinhua Hospital, Shanghai Institute for Pediatric Research, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Neurology, Jiangxi Provincial Children's Hospital, Nanchang, China.
- Department of Human Medicine and Institute for Molecular Medicine, MSH Medical School Hamburg, Hamburg, Germany.
ORCID-Profile: Hailan He, Hui Chen, Fang He, Fei Yin, Tobias Stauber, Xiaomin Zou, Jing Peng
Förderung
- Key R & D Program of Hunan Province
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
He, H., Zhang, H., Chen, H., He, F., Yin, F., Stauber, T., Zou, X., & Peng, J. (2023). Functional analysis of two SLC9A6 frameshift variants in lymphoblastoid cells from patients with Christianson syndrome. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14329
Vancouver
He H, Zhang H, Chen H, He F, Yin F, Stauber T, et al. Functional analysis of two SLC9A6 frameshift variants in lymphoblastoid cells from patients with Christianson syndrome. CNS Neuroscience & Therapeutics. 2023. doi:10.1111/cns.14329
BibTeX
@article{He2023,
author = {He, Hailan and Zhang, Huiwen and Chen, Hui and He, Fang and Yin, Fei and Stauber, Tobias and Zou, Xiaomin and Peng, Jing},
title = {Functional analysis of two SLC9A6 frameshift variants in lymphoblastoid cells from patients with Christianson syndrome},
journal = {CNS Neuroscience & Therapeutics},
year = {2023},
doi = {10.1111/cns.14329}
}
EUVIMED